\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\:\\ t\\=35\\.9\\,\\ p\\=63\\,\\ r\\=20\\ bp\\=106\\/41\ \(0\)\
\-\ pt\\ is\\ follows\\ simple\\ commands\\,\\ continues\\ to\\ be\\ non\\-verbal\\,\\ perrla\\,\\ neurological\\ exam\\ is\\ grossly\\ intact\\.\\ the\\ pt\\ has\\ numerous\\ scars\\ on\\ her\\ extremities\\,\\ sebaceous\\ adenomas\\ on\\ her\\ face\\,\\ as\\ well\\ as\\ a\\ shagreen\\ patch\\ on\\ her\\ forehead\\.\\ \\ there\\ are\\ areas\\ of\\ cutaneous\\ hyperpigmentation\\ on\\ her\\ back\\.\ \(0\)\
\-\ the\\ main\\ complication\\ of\\ tuberous\\ sclerosis\\ requiring\\ long\\ term\\ therapy\\ is\\ seizure\\ disorders\\,\\ as\\ was\\ this\\ case\\ with\\ our\\ patient\\.\\ \\ she\\ was\\ placed\\ on\\ antiepileptic\\ medication\\ and\\ has\\ spent\\ much\\ of\\ her\\ childhood\\ in\\ institutions\\ due\\ to\\ her\\ behavioral\\ and\\ developmental\\ delays\\ as\\ well\\ as\\ poor\\ family\\ support\\.\\ \\ in\\ oct\\ 2006\\ she\\ had\\ a\\ peg\\ tube\\ placed\\ for\\ poor\\ feeding\\ and\\ is\\ being\\ closely\\ monitored\\ by\\ her\\ pcp\\ and\\ a\\ neurologist\\.\\ \\ standards\\ currently\\ suggest\\ follow\\-up\\ mris\\ every\\ 1\\-3\\ years\\ in\\ children\\ with\\ tuberous\\ sclerosis\\.\\ options\\ for\\ treatment\\ outside\\ of\\ antiepileptic\\ medications\\ include\\ immunosuppressive\\ therapy\\,\\ surgical\\ resection\\ such\\ as\\ focal\\ cortical\\ resection\\,\\ corpus\\ callosotomy\\ \\,\\ or\\ vagal\\ stimulation\\.\\ \\ since\\ subependymal\\ giant\\ cell\\ astrocytomas\\ are\\ associated\\ with\\ tuberous\\ sclerosis\\ and\\ can\\ cause\\ hydrocephalus\\,\\ surgical\\ resection\\ may\\ be\\ indicated\\.\ \(0\)\
\-\ mri\\ of\\ the\\ brain\\ w\\/o\\ iv\\ contrast\\.\\ \\ the\\ \\ ventricles\\ \\ are\\ increased\\ \\ slightly\\ \\ in\\ \\ size\\ \\ which\\ most\\ likely\\ represent\\ \\ mild\\ \\ atrophy\\.\\ \\ \\ \\ approximately\\ six\\ subependymal\\ lesions\\ \\ are\\ \\ identified\\ \\ in\\ the\\ lateral\\ ventricles\\ bilaterally\\ with\\ enhancement\\ \\ of\\ \\ the\\ \\ largest\\ \\ lesion\\ \\ in\\ \\ the\\ right\\ \\ lateral\\ \\ ventricle\\ \\ which\\ \\ measures\\ \\ approximately\\ \\ 1\\.1\\ \\ cm\\ \\ in\\ \\ its\\ greatest\\ \\ diameter\\.\\ \\ \\ these\\ appear\\ unchanged\\ from\\ previous\\ studies\\.\\ \\ \\ noted\\ \\ are\\ \\ the\\ \\ multiple\\ \\ areas\\ \\ of\\ \\ abnormal\\ \\ t2\\ \\ prolongation\\ \\ scattered\\ \\ throughout\\ \\ the\\ cerebral\\ \\ hemispheres\\.\\ \\ \\ \\ these\\ \\ are\\ \\ grossly\\ \\ unchanged\\ \\ when\\ compared\\ \\ with\\ previous\\ \\ studies\\.\\ \\ \\ there\\ is\\ no\\ increase\\ \\ in\\ \\ the\\ extra\\-axial\\ \\ fluid\\.\\ \\ \\ \\ there\\ \\ is\\ \\ no\\ \\ evidence\\ \\ of\\ \\ cerebellar\\ \\ ectopia\\.\\ \\ \\ \\ the\\ anterior\\ \\ pituitary\\ \\ is\\ noted\\ \\ to\\ \\ be\\ \\ concaved\\ \\ but\\ \\ is\\ \\ grossly\\ \\ unchanged\\ \\ when\\ \\ compared\\ \\ with\\ \\ previous\\ \\ studies\\.\\ \\ \\ \\ the\\ \\ corpus\\ \\ callosum\\ \\ is\\ \\ somewhat\\ \\ thin\\.\ \(0\)\
\-\ tuberous\\ sclerosis\\ \\(bourneville\\ disease\\)\ \(0\)\
\-\ complex\\ partial\\ seizures\\ \ \(2\)\
\-\ tuberous\\ sclerosis\ \(40\)\
\-\ hydrocephalus\\ \ \(74\)\
\-\ lennox\\-gastaut\\ syndrome\\ \ \(0\)\
\-\ giant\\ cell\\ astrocytoma\ \(5\)\
\-\ 16\\ y\\/o\\ white\\ female\\ who\\ presented\\ to\\ the\\ er\\ with\\ her\\ mother\\ with\\ c\\/o\\ increasing\\ seizure\\ activity\\,\\ increased\\ self\\-mutilation\\,\\ and\\ violence\\ towards\\ others\\.\\ \\ pt\\ has\\ longstanding\\ hx\\ of\\ problems\\ since\\ birth\\ to\\ include\\ autism\\,\\ mental\\ retardation\\,\\ \\ developmental\\ delay\\,\\ as\\ well\\ as\\ seizure\\ disorder\\.\\ the\\ pt\\ is\\ non\\-verbal\\.\\ the\\ patient\\ was\\ being\\ followed\\ at\\ another\\ facility\\,\\ however\\,\\ due\\ to\\ a\\ recent\\ move\\,\\ her\\ family\\ now\\ wishes\\ to\\ have\\ her\\ care\\ in\\ your\\ facility\\.\ \(0\)\
\-\ as\\ is\\ the\\ case\\ with\\ more\\ than\\ 90\\ percent\\ of\\ tuberous\\ sclerosis\\ patients\\ with\\ brain\\ involvement\\,\\ this\\ patient\\ presented\\ to\\ the\\ er\\ with\\ convulsions\\.\\ \\ though\\ her\\ underlying\\ hx\\ of\\ seizures\\ disorder\\ complicates\\ the\\ picture\\,\\ it\\ is\\ likely\\ that\\ some\\ of\\ the\\ problems\\ she\\ is\\ having\\ are\\ manifestation\\ of\\ her\\ tuberous\\ sclerosis\\.\\ \\ in\\ addition\\,\\ this\\ patient\\,\\ like\\ 50\\-85\\ percent\\ of\\ those\\ affected\\ by\\ tuberous\\ sclerosis\\ has\\ severe\\ developmental\\ delay\\.\\ \\ she\\ also\\ had\\ the\\ skin\\ manifestation\\ that\\ are\\ characteristic\\ in\\ more\\ than\\ 80\\ percent\\ of\\ patient\\'s\\ to\\ include\\ shagreen\\ patches\\ and\\ sebaceous\\ adenomas\\ on\\ her\\ face\\.\\ \\ this\\ patient\\'s\\ condition\\ was\\ being\\ managed\\ conservatively\\ with\\ antiepileptic\\ medication\\ and\\ routine\\ follow\\-up\\ mris\\.\\ interestingly\\,\\ within\\ the\\ past\\ year\\ the\\ patient\\ also\\ had\\ renal\\ us\\ done\\ due\\ to\\ possible\\ renal\\ cysts\\ versus\\ tumors\\,\\ which\\ can\\ be\\ found\\ in\\ up\\ to\\ 80\\ percent\\ of\\ patients\\ with\\ tuberous\\ sclerosis\\.\\ \\ however\\,\\ at\\ the\\ time\\ of\\ this\\ posting\\,\\ the\\ final\\ results\\ are\\ not\\ known\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tuberous\\:\\ 0\\.07080568735474696\ \(0\)\
\-\ her\\:\\ 0\\.05585677518445512\ \(0\)\
\-\ sclerosis\\:\\ 0\\.046193707526483455\ \(0\)\
\-\ antiepileptic\\:\\ 0\\.03615090557624949\ \(0\)\
\-\ percent\\:\\ 0\\.031148062478975422\ \(0\)\
\-\ unchanged\\:\\ 0\\.026997648258267653\ \(0\)\
\-\ non\\-verbal\\:\\ 0\\.02580905061972705\ \(0\)\
\-\ shagreen\\:\\ 0\\.02580905061972705\ \(0\)\
\-\ grossly\\:\\ 0\\.022498921824482446\ \(0\)\
\-\ pt\\:\\ 0\\.0212519314691154\ \(0\)\
\-\ sebaceous\\:\\ 0\\.020426315126636414\ \(0\)\
\-\ mris\\:\\ 0\\.020426315126636414\ \(0\)\
\-\ developmental\\:\\ 0\\.019923066910574785\ \(0\)\
\-\ as\\:\\ 0\\.01945350761379122\ \(0\)\
\-\ adenomas\\:\\ 0\\.018996736481730263\ \(0\)\
\-\ seizure\\:\\ 0\\.018956015827188307\ \(0\)\
\-\ manifestation\\:\\ 0\\.018460473438000564\ \(0\)\
\-\ are\\:\\ 0\\.01753154657653247\ \(0\)\
\-\ subependymal\\:\\ 0\\.017063365743351808\ \(0\)\
\-\ previous\\:\\ 0\\.016647241799364363\ \(0\)\
\-\ she\\:\\ 0\\.01604539225052958\ \(0\)\
\-\ studies\\:\\ 0\\.01601087416946067\ \(0\)\
\-\ facility\\:\\ 0\\.01562670132968216\ \(0\)\
\-\ being\\:\\ 0\\.014938735669568019\ \(0\)\
\-\ medication\\:\\ 0\\.014396852566721232\ \(0\)\
\-\ delay\\:\\ 0\\.014183302493187677\ \(0\)\
\-\ hx\\:\\ 0\\.01414899981704323\ \(0\)\
\-\ corpus\\:\\ 0\\.014081432234041492\ \(0\)\
\-\ face\\:\\ 0\\.014015202711311795\ \(0\)\
\-\ giant\\:\\ 0\\.013762669090883216\ \(0\)\
\-\ t\\=35\\.9\\:\\ 0\\.013582560607703265\ \(0\)\
\-\ p\\=63\\:\\ 0\\.013582560607703265\ \(0\)\
\-\ r\\=20\\:\\ 0\\.013582560607703265\ \(0\)\
\-\ bp\\=106\\/41\\:\\ 0\\.013582560607703265\ \(0\)\
\-\ callosotomy\\:\\ 0\\.013582560607703265\ \(0\)\
\-\ concaved\\:\\ 0\\.013582560607703265\ \(0\)\
\-\ self\\-mutilation\\:\\ 0\\.013582560607703265\ \(0\)\
\-\ convulsions\\:\\ 0\\.013582560607703265\ \(0\)\
\-\ posting\\:\\ 0\\.013582560607703265\ \(0\)\
\-\ ventricles\\:\\ 0\\.01344390594772494\ \(0\)\
\-\ 80\\:\\ 0\\.01344390594772494\ \(0\)\
\-\ resection\\:\\ 0\\.013369142084549592\ \(0\)\
\-\ problems\\:\\ 0\\.013229786018745237\ \(0\)\
\-\ bourneville\\:\\ 0\\.012904525309863525\ \(0\)\
\-\ violence\\:\\ 0\\.012904525309863525\ \(0\)\
\-\ 50\\-85\\:\\ 0\\.012904525309863525\ \(0\)\
\-\ poor\\:\\ 0\\.012861890048128754\ \(0\)\
\-\ disorder\\:\\ 0\\.012838744754334193\ \(0\)\
\-\ \\,\\:\\ 0\\.012675387683083688\ \(0\)\
\-\ standards\\:\\ 0\\.012423451610111384\ \(0\)\
\-\ immunosuppressive\\:\\ 0\\.012423451610111384\ \(0\)\
\-\ lennox\\-gastaut\\:\\ 0\\.012423451610111384\ \(0\)\
\-\ autism\\:\\ 0\\.012423451610111384\ \(0\)\
\-\ wishes\\:\\ 0\\.012423451610111384\ \(0\)\
\-\ complicates\\:\\ 0\\.012423451610111384\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.01228714002496267\ \(0\)\
\-\ seizures\\:\\ 0\\.01228714002496267\ \(0\)\
\-\ is\\:\\ 0\\.012223712573580991\ \(0\)\
\-\ compared\\:\\ 0\\.012097061514049072\ \(0\)\
\-\ behavioral\\:\\ 0\\.01205030185874983\ \(0\)\
\-\ include\\:\\ 0\\.012025853618881038\ \(0\)\
\-\ hyperpigmentation\\:\\ 0\\.011745416312271644\ \(0\)\
\-\ delays\\:\\ 0\\.011745416312271644\ \(0\)\
\-\ peg\\:\\ 0\\.011745416312271644\ \(0\)\
\-\ family\\:\\ 0\\.01171341954824318\ \(0\)\
\-\ placed\\:\\ 0\\.011568334947473195\ \(0\)\
\-\ institutions\\:\\ 0\\.011487639255704323\ \(0\)\
\-\ due\\:\\ 0\\.011439517489729965\ \(0\)\
\-\ spent\\:\\ 0\\.011264342612519502\ \(0\)\
\-\ vagal\\:\\ 0\\.011264342612519502\ \(0\)\
\-\ er\\:\\ 0\\.010963826611866092\ \(0\)\
\-\ has\\:\\ 0\\.010733779066851357\ \(0\)\
\-\ patches\\:\\ 0\\.010586307314679761\ \(0\)\
\-\ since\\:\\ 0\\.010497540540796711\ \(0\)\
\-\ 1\\-3\\:\\ 0\\.01045245663295144\ \(0\)\
\-\ commands\\:\\ 0\\.01032853025811244\ \(0\)\
\-\ prolongation\\:\\ 0\\.01010523361492762\ \(0\)\
\-\ patient\\:\\ 0\\.01002699584684735\ \(0\)\
\-\ neurologist\\:\\ 0\\.010003854648679401\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.009908272016840023\ \(0\)\
\-\ patch\\:\\ 0\\.009817858603344578\ \(0\)\
\-\ well\\:\\ 0\\.009697730533287548\ \(0\)\
\-\ retardation\\:\\ 0\\.0096504949602727\ \(0\)\
\-\ areas\\:\\ 0\\.009616545723230993\ \(0\)\
\-\ scars\\:\\ 0\\.009572702291986927\ \(0\)\
\-\ your\\:\\ 0\\.009572702291986927\ \(0\)\
\-\ oct\\:\\ 0\\.009498368240865132\ \(0\)\
\-\ longstanding\\:\\ 0\\.009498368240865132\ \(0\)\
\-\ interestingly\\:\\ 0\\.009498368240865132\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.009297782580072715\ \(0\)\
\-\ forehead\\:\\ 0\\.009293347635359559\ \(0\)\
\-\ ectopia\\:\\ 0\\.009293347635359559\ \(0\)\
\-\ had\\:\\ 0\\.009250082705220944\ \(0\)\
\-\ perrla\\:\\ 0\\.009230236719000282\ \(0\)\
\-\ move\\:\\ 0\\.009230236719000282\ \(0\)\
\-\ pcp\\:\\ 0\\.009054048565726325\ \(0\)\
\-\ stimulation\\:\\ 0\\.008894666994147187\ \(0\)\
\-\ 1\\.1\\:\\ 0\\.008894666994147187\ \(0\)\
\-\ towards\\:\\ 0\\.00884474565108752\ \(0\)\
\-\ approximately\\:\\ 0\\.008842200088814658\ \(0\)\
\-\ be\\:\\ 0\\.008814426243103204\ \(0\)\
\-\ closely\\:\\ 0\\.00861531233751982\ \(0\)\
\-\ monitored\\:\\ 0\\.00861531233751982\ \(0\)\
\-\ brain\\:\\ 0\\.0085998378705778\ \(0\)\
\-\ renal\\:\\ 0\\.008586874747351403\ \(0\)\
\-\ in\\:\\ 0\\.0084561317085001\ \(0\)\
\-\ others\\:\\ 0\\.008413593294395045\ \(0\)\
\-\ c\\/o\\:\\ 0\\.008376013267886586\ \(0\)\
\-\ picture\\:\\ 0\\.008376013267886586\ \(0\)\
\-\ cutaneous\\:\\ 0\\.00830329568939204\ \(0\)\
\-\ 2006\\:\\ 0\\.008233608906113497\ \(0\)\
\-\ when\\:\\ 0\\.008185054306408045\ \(0\)\
\-\ largest\\:\\ 0\\.008102385468920363\ \(0\)\
\-\ w\\/o\\:\\ 0\\.008071127721408401\ \(0\)\
\-\ likely\\:\\ 0\\.008061170454634302\ \(0\)\
\-\ childhood\\:\\ 0\\.00804044354303349\ \(0\)\
\-\ this\\:\\ 0\\.008036264325369006\ \(0\)\
\-\ which\\:\\ 0\\.008002397594862284\ \(0\)\
\-\ however\\:\\ 0\\.007957752694304583\ \(0\)\
\-\ conservatively\\:\\ 0\\.007951631126120533\ \(0\)\
\-\ requiring\\:\\ 0\\.007894939568134444\ \(0\)\
\-\ greatest\\:\\ 0\\.007894939568134444\ \(0\)\
\-\ to\\:\\ 0\\.007855767881058276\ \(0\)\
\-\ presented\\:\\ 0\\.0077904937626167535\ \(0\)\
\-\ cell\\:\\ 0\\.007719868600606977\ \(0\)\
\-\ final\\:\\ 0\\.00771041104444069\ \(0\)\
\-\ follows\\:\\ 0\\.007685636653495638\ \(0\)\
\-\ managed\\:\\ 0\\.007685636653495638\ \(0\)\
\-\ support\\:\\ 0\\.007661223945433509\ \(0\)\
\-\ therapy\\:\\ 0\\.007640939117861582\ \(0\)\
\-\ hemispheres\\:\\ 0\\.007613442386162513\ \(0\)\
\-\ extra\\-axial\\:\\ 0\\.007613442386162513\ \(0\)\
\-\ every\\:\\ 0\\.007590054021656259\ \(0\)\
\-\ than\\:\\ 0\\.007488457708756769\ \(0\)\
\-\ continues\\:\\ 0\\.007456203339927937\ \(0\)\
\-\ these\\:\\ 0\\.007437607665410836\ \(0\)\
\-\ patients\\:\\ 0\\.007396570566441558\ \(0\)\
\-\ atrophy\\:\\ 0\\.007372573874084022\ \(0\)\
\-\ feeding\\:\\ 0\\.007332276965088936\ \(0\)\
\-\ callosum\\:\\ 0\\.007332276965088936\ \(0\)\
\-\ on\\:\\ 0\\.007263120525405633\ \(0\)\
\-\ pituitary\\:\\ 0\\.007162071790657595\ \(0\)\
\-\ more\\:\\ 0\\.007147746853886844\ \(0\)\
\-\ simple\\:\\ 0\\.007040716117020746\ \(0\)\
\-\ six\\:\\ 0\\.0070240767677679575\ \(0\)\
\-\ somewhat\\:\\ 0\\.0070240767677679575\ \(0\)\
\-\ complication\\:\\ 0\\.0070076013556558975\ \(0\)\
\-\ increased\\:\\ 0\\.0069915878989955035\ \(0\)\
\-\ options\\:\\ 0\\.0069432764713284805\ \(0\)\
\-\ birth\\:\\ 0\\.0068662010412277\ \(0\)\
\-\ vitals\\:\\ 0\\.006836338804772839\ \(0\)\
\-\ disorders\\:\\ 0\\.006836338804772839\ \(0\)\
\-\ our\\:\\ 0\\.006792522128528652\ \(0\)\
\-\ versus\\:\\ 0\\.006792522128528652\ \(0\)\
\-\ noted\\:\\ 0\\.006773983907868206\ \(0\)\
\-\ 90\\:\\ 0\\.006735830570542563\ \(0\)\
\-\ mental\\:\\ 0\\.006667566365659193\ \(0\)\
\-\ main\\:\\ 0\\.006654241667249198\ \(0\)\
\-\ scattered\\:\\ 0\\.006654241667249198\ \(0\)\
\-\ though\\:\\ 0\\.006627906622151975\ \(0\)\
\-\ much\\:\\ 0\\.006614893009372618\ \(0\)\
\-\ like\\:\\ 0\\.006614893009372618\ \(0\)\
\-\ was\\:\\ 0\\.006610551988051417\ \(0\)\
\-\ having\\:\\ 0\\.006563828253753753\ \(0\)\
\-\ term\\:\\ 0\\.006538868972454964\ \(0\)\
\-\ mother\\:\\ 0\\.0065265276559037565\ \(0\)\
\-\ those\\:\\ 0\\.006502114947841628\ \(0\)\
\-\ can\\:\\ 0\\.0064823490049132765\ \(0\)\
\-\ 16\\:\\ 0\\.006466151393960418\ \(0\)\
\-\ numerous\\:\\ 0\\.006407879267990238\ \(0\)\
\-\ there\\:\\ 0\\.006379843928754124\ \(0\)\
\-\ medications\\:\\ 0\\.006373866418095383\ \(0\)\
\-\ \\'s\\:\\ 0\\.006301159258752659\ \(0\)\
\-\ represent\\:\\ 0\\.006275791623644701\ \(0\)\
\-\ case\\:\\ 0\\.006252523186847059\ \(0\)\
\-\ neurological\\:\\ 0\\.006183151524330674\ \(0\)\
\-\ indicated\\:\\ 0\\.006183151524330674\ \(0\)\
\-\ affected\\:\\ 0\\.006183151524330674\ \(0\)\
\-\ lateral\\:\\ 0\\.006176147309781104\ \(0\)\
\-\ children\\:\\ 0\\.006173167967497055\ \(0\)\
\-\ cerebellar\\:\\ 0\\.006163243660607734\ \(0\)\
\-\ another\\:\\ 0\\.006143570012481335\ \(0\)\
\-\ underlying\\:\\ 0\\.006124125132890834\ \(0\)\
\-\ measures\\:\\ 0\\.0061144868306889115\ \(0\)\
\-\ suggest\\:\\ 0\\.006085900821726871\ \(0\)\
\-\ addition\\:\\ 0\\.0060577952727028225\ \(0\)\
\-\ characteristic\\:\\ 0\\.006048530757024536\ \(0\)\
\-\ tube\\:\\ 0\\.006021041248089486\ \(0\)\
\-\ diameter\\:\\ 0\\.006011977590114003\ \(0\)\
\-\ surgical\\:\\ 0\\.006007430669737303\ \(0\)\
\-\ outside\\:\\ 0\\.005993996332963062\ \(0\)\
\-\ increase\\:\\ 0\\.005993996332963062\ \(0\)\
\-\ us\\:\\ 0\\.005993996332963062\ \(0\)\
\-\ condition\\:\\ 0\\.005976206369409457\ \(0\)\
\-\ done\\:\\ 0\\.005923944590974501\ \(0\)\
\-\ thin\\:\\ 0\\.005873266749009068\ \(0\)\
\-\ increasing\\:\\ 0\\.00585670977412159\ \(0\)\
\-\ appear\\:\\ 0\\.005848492358064016\ \(0\)\
\-\ slightly\\:\\ 0\\.005776298090730891\ \(0\)\
\-\ results\\:\\ 0\\.005768465566797068\ \(0\)\
\-\ routine\\:\\ 0\\.005729843970150497\ \(0\)\
\-\ complex\\:\\ 0\\.005722225547849727\ \(0\)\
\-\ partial\\:\\ 0\\.005714641676335694\ \(0\)\
\-\ currently\\:\\ 0\\.005662496312729193\ \(0\)\
\-\ also\\:\\ 0\\.005634179243043985\ \(0\)\
\-\ extremities\\:\\ 0\\.0056048271219747295\ \(0\)\
\-\ cysts\\:\\ 0\\.005597756325804961\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.005549080599788121\ \(0\)\
\-\ the\\:\\ 0\\.005548466275730801\ \(0\)\
\-\ skin\\:\\ 0\\.0054885099251487926\ \(0\)\
\-\ its\\:\\ 0\\.005392193049256925\ \(0\)\
\-\ tumors\\:\\ 0\\.005367418658311874\ \(0\)\
\-\ activity\\:\\ 0\\.0053612819879289945\ \(0\)\
\-\ ventricle\\:\\ 0\\.005355167755147872\ \(0\)\
\-\ throughout\\:\\ 0\\.0053490757964881714\ \(0\)\
\-\ intact\\:\\ 0\\.0052487702703983554\ \(0\)\
\-\ involvement\\:\\ 0\\.005237355613089994\ \(0\)\
\-\ iv\\:\\ 0\\.005214757420503501\ \(0\)\
\-\ cortical\\:\\ 0\\.005209155268521425\ \(0\)\
\-\ care\\:\\ 0\\.005154142386402596\ \(0\)\
\-\ identified\\:\\ 0\\.005106132175896858\ \(0\)\
\-\ cerebral\\:\\ 0\\.0049505794343880785\ \(0\)\
\-\ that\\:\\ 0\\.0049363903965178035\ \(0\)\
\-\ long\\:\\ 0\\.004926791824134989\ \(0\)\
\-\ now\\:\\ 0\\.004884808678430849\ \(0\)\
\-\ cause\\:\\ 0\\.004834887335371181\ \(0\)\
\-\ possible\\:\\ 0\\.004812679295792762\ \(0\)\
\-\ recent\\:\\ 0\\.0048038780080933065\ \(0\)\
\-\ size\\:\\ 0\\.0047907623267203535\ \(0\)\
\-\ followed\\:\\ 0\\.0047907623267203535\ \(0\)\
\-\ by\\:\\ 0\\.004758765562691889\ \(0\)\
\-\ white\\:\\ 0\\.004739304703531802\ \(0\)\
\-\ back\\:\\ 0\\.0047141577514171855\ \(0\)\
\-\ bilaterally\\:\\ 0\\.004693487020942982\ \(0\)\
\-\ past\\:\\ 0\\.00454046734439203\ \(0\)\
\-\ known\\:\\ 0\\.004521824555959565\ \(0\)\
\-\ found\\:\\ 0\\.004503387315137311\ \(0\)\
\-\ such\\:\\ 0\\.004467111688697077\ \(0\)\
\-\ severe\\:\\ 0\\.004396839130545158\ \(0\)\
\-\ some\\:\\ 0\\.004339344906131704\ \(0\)\
\-\ years\\:\\ 0\\.004196058757555991\ \(0\)\
\-\ syndrome\\:\\ 0\\.004086800295542879\ \(0\)\
\-\ focal\\:\\ 0\\.0040810929835090335\ \(0\)\
\-\ abnormal\\:\\ 0\\.004075405084138647\ \(0\)\
\-\ fluid\\:\\ 0\\.004061269405692062\ \(0\)\
\-\ t2\\:\\ 0\\.004044462823997244\ \(0\)\
\-\ time\\:\\ 0\\.004036122453577446\ \(0\)\
\-\ y\\/o\\:\\ 0\\.003957573628460938\ \(0\)\
\-\ at\\:\\ 0\\.0038721175679987726\ \(0\)\
\-\ up\\:\\ 0\\.0038425537643047214\ \(0\)\
\-\ cm\\:\\ 0\\.0038327025381554945\ \(0\)\
\-\ enhancement\\:\\ 0\\.0038302487727809964\ \(0\)\
\-\ lesions\\:\\ 0\\.0038253520172975715\ \(0\)\
\-\ mild\\:\\ 0\\.0037629656420253127\ \(0\)\
\-\ evidence\\:\\ 0\\.0037465595039579895\ \(0\)\
\-\ who\\:\\ 0\\.0037256996808389667\ \(0\)\
\-\ anterior\\:\\ 0\\.003680255558131668\ \(0\)\
\-\ associated\\:\\ 0\\.0033720109730898023\ \(0\)\
\-\ of\\:\\ 0\\.0033119809591401392\ \(0\)\
\-\ most\\:\\ 0\\.0032990554209499597\ \(0\)\
\-\ mri\\:\\ 0\\.00328306999149602\ \(0\)\
\-\ it\\:\\ 0\\.003212121044369593\ \(0\)\
\-\ contrast\\:\\ 0\\.0031986215498459956\ \(0\)\
\-\ exam\\:\\ 0\\.003139187190551067\ \(0\)\
\-\ may\\:\\ 0\\.003134328376083819\ \(0\)\
\-\ have\\:\\ 0\\.0030943780574667085\ \(0\)\
\-\ but\\:\\ 0\\.003047664382999227\ \(0\)\
\-\ multiple\\:\\ 0\\.0030097090359185097\ \(0\)\
\-\ female\\:\\ 0\\.0029377262064345044\ \(0\)\
\-\ lesion\\:\\ 0\\.002910627468228185\ \(0\)\
\-\ treatment\\:\\ 0\\.0028923360528442924\ \(0\)\
\-\ no\\:\\ 0\\.002877739634460876\ \(0\)\
\-\ within\\:\\ 0\\.002725972254826223\ \(0\)\
\-\ a\\:\\ 0\\.002652841483736463\ \(0\)\
\-\ with\\:\\ 0\\.0025435690454323856\ \(0\)\
\-\ for\\:\\ 0\\.0024384887914472076\ \(0\)\
\-\ and\\:\\ 0\\.002408147233875832\ \(0\)\
\-\ disease\\:\\ 0\\.0023356815070496723\ \(0\)\
\-\ from\\:\\ 0\\.002117785473502027\ \(0\)\
\-\ not\\:\\ 0\\.002064914166792534\ \(0\)\
\-\ \\:\\:\\ 0\\.0018900916655362292\ \(0\)\
\-\ \\.\\:\\ 0\\.0017809131821411176\ \(0\)\
\-\ or\\:\\ 0\\.001674787205624929\ \(0\)\
\-\ year\\:\\ 0\\.0015988382429312955\ \(0\)\
\-\ right\\:\\ 0\\.001507745332960563\ \(0\)\
\-\ \\(\\:\\ 0\\.0012079627529161547\ \(0\)\
\-\ \\)\\:\\ 0\\.0011932068429988379\ \(0\)\
